These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11823278)

  • 1. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
    van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
    Malison RT; McDougle CJ; van Dyck CH; Scahill L; Baldwin RM; Seibyl JP; Price LH; Leckman JF; Innis RB
    Am J Psychiatry; 1995 Sep; 152(9):1359-61. PubMed ID: 7653693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.
    Malison RT; Best SE; van Dyck CH; McCance EF; Wallace EA; Laruelle M; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
    Am J Psychiatry; 1998 Jun; 155(6):832-4. PubMed ID: 9619159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis.
    Fusar-Poli P; Rubia K; Rossi G; Sartori G; Balottin U
    Am J Psychiatry; 2012 Mar; 169(3):264-72. PubMed ID: 22294258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
    Hesse S; Ballaschke O; Barthel H; Sabri O
    Psychiatry Res; 2009 Feb; 171(2):120-8. PubMed ID: 19176281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
    Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
    J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry.
    Riikonen RS; Nokelainen P; Valkonen K; Kolehmainen AI; Kumpulainen KI; Könönen M; Vanninen RL; Kuikka JT
    Biol Psychiatry; 2005 Jun; 57(12):1565-72. PubMed ID: 15953494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.
    Best SE; Sarrel PM; Malison RT; Laruelle M; Zoghbi SS; Baldwin RM; Seibyl JP; Innis RB; van Dyck CH
    Psychopharmacology (Berl); 2005 Dec; 183(2):181-9. PubMed ID: 16175405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.
    Laakso A; Vilkman H; Alakare B; Haaparanta M; Bergman J; Solin O; Peurasaari J; Räkköläinen V; Syvälahti E; Hietala J
    Am J Psychiatry; 2000 Feb; 157(2):269-71. PubMed ID: 10671399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.